MAPK11 and Huntington disease: Finally, heterozygous or homozygous deletion of Mapk11 lowers mHTT aggregates in HD striata and rescues the behavioral phenotypes of the HD mice in vivo, confirming the therapeutic potential of reducing the activity of this protein kinase.